Shanghai Hengrui Pharmaceutical Co., Ltd.

This early-stage study tested an experimental drug called SHR-1707 in 33 people with mild memory problems or mild Alzheimer's disease. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked at whether it could reduce sticky plaques in …

This study looked at the long-term safety and effectiveness of the drug SHR-1819 in 79 adults with moderate to severe atopic dermatitis (eczema) who had already taken part in earlier studies of the same drug. Researchers monitored side effects and how well the drug controlled the…

This study tested a new medicine called SHR6508 in 498 adults with kidney failure who were on dialysis and had secondary hyperparathyroidism (overactive parathyroid glands). The goal was to see if the drug could safely lower parathyroid hormone levels. Participants received eithe…

This study tested an experimental injection called SHR-1819 in 158 adults with moderate to severe atopic dermatitis (eczema). The goal was to see if it safely reduces skin redness, itching, and rash. Participants received either the drug or a placebo, and doctors measured improve…

This study looked at how a drug called SHR6508 is processed and removed from the body in 5 Chinese patients on hemodialysis who have secondary hyperparathyroidism. The goal was to understand the drug's breakdown and excretion, not to treat the condition. Participants received a s…